ONS Connections: Reliable biomarker for central nervous system tissue injury during pediatric leukemia treatment
During the post-induction phase of treatment for childhood acute lymphoblastic leukemia (ALL), F2 isoprostanes significantly increase, allowing central nervous system (CNS) tissue injury to be monitored.